Global Immunoglobulin G Antibody Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201050261 | Category: Pharma & Healthcare | Pages: 101 | Format: PDF | Published Date: July 11,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Immunoglobulin G Antibody Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Immunoglobulin G Antibody Therapeutics market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Autoimmune accounting for  % of the Immunoglobulin G Antibody Therapeutics global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While IgG1 segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Immunoglobulin G Antibody Therapeutics include Roche, Abbvie, J & J, Bristol-Myers Squibb, and Novartis, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Immunoglobulin G Antibody Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    IgG1
    IgG4
    Others
Market segment by Application, can be divided into
    Autoimmune
    Tumor
    Others
Market segment by players, this report covers
    Roche
    Abbvie
    J & J
    Bristol-Myers Squibb
    Novartis
    Merck
    Alexion Pharmaceuticals
    Takeda
    Amgen
    Biogen
    UCB
    Eli Lilly and Company
    AstraZeneca
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Immunoglobulin G Antibody Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Immunoglobulin G Antibody Therapeutics, with revenue, gross margin and global market share of Immunoglobulin G Antibody Therapeutics from 2019 to 2022.
Chapter 3, the Immunoglobulin G Antibody Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Immunoglobulin G Antibody Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Immunoglobulin G Antibody Therapeutics research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Immunoglobulin G Antibody Therapeutics
    1.2 Classification of Immunoglobulin G Antibody Therapeutics by Type
        1.2.1 Overview: Global Immunoglobulin G Antibody Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type in 2021
        1.2.3 IgG1
        1.2.4 IgG4
        1.2.5 Others
    1.3 Global Immunoglobulin G Antibody Therapeutics Market by Application
        1.3.1 Overview: Global Immunoglobulin G Antibody Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Autoimmune
        1.3.3 Tumor
        1.3.4 Others
    1.4 Global Immunoglobulin G Antibody Therapeutics Market Size & Forecast
    1.5 Global Immunoglobulin G Antibody Therapeutics Market Size and Forecast by Region
        1.5.1 Global Immunoglobulin G Antibody Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Immunoglobulin G Antibody Therapeutics Market Size by Region, (2017-2022)
        1.5.3 North America Immunoglobulin G Antibody Therapeutics Market Size and Prospect (2017-2028)
        1.5.4 Europe Immunoglobulin G Antibody Therapeutics Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size and Prospect (2017-2028)
        1.5.6 South America Immunoglobulin G Antibody Therapeutics Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Immunoglobulin G Antibody Therapeutics Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Immunoglobulin G Antibody Therapeutics Market Drivers
        1.6.2 Immunoglobulin G Antibody Therapeutics Market Restraints
        1.6.3 Immunoglobulin G Antibody Therapeutics Trends Analysis
2 Company Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.1.4 Roche Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Roche Recent Developments and Future Plans
    2.2 Abbvie
        2.2.1 Abbvie Details
        2.2.2 Abbvie Major Business
        2.2.3 Abbvie Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.2.4 Abbvie Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Abbvie Recent Developments and Future Plans
    2.3 J & J
        2.3.1 J & J Details
        2.3.2 J & J Major Business
        2.3.3 J & J Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.3.4 J & J Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 J & J Recent Developments and Future Plans
    2.4 Bristol-Myers Squibb
        2.4.1 Bristol-Myers Squibb Details
        2.4.2 Bristol-Myers Squibb Major Business
        2.4.3 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.4.4 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.5.4 Novartis Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Novartis Recent Developments and Future Plans
    2.6 Merck
        2.6.1 Merck Details
        2.6.2 Merck Major Business
        2.6.3 Merck Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.6.4 Merck Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Merck Recent Developments and Future Plans
    2.7 Alexion Pharmaceuticals
        2.7.1 Alexion Pharmaceuticals Details
        2.7.2 Alexion Pharmaceuticals Major Business
        2.7.3 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.7.4 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Alexion Pharmaceuticals Recent Developments and Future Plans
    2.8 Takeda
        2.8.1 Takeda Details
        2.8.2 Takeda Major Business
        2.8.3 Takeda Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.8.4 Takeda Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Takeda Recent Developments and Future Plans
    2.9 Amgen
        2.9.1 Amgen Details
        2.9.2 Amgen Major Business
        2.9.3 Amgen Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.9.4 Amgen Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Amgen Recent Developments and Future Plans
    2.10 Biogen 
        2.10.1 Biogen Details
        2.10.2 Biogen Major Business
        2.10.3 Biogen Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.10.4 Biogen Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Biogen Recent Developments and Future Plans
    2.11 UCB
        2.11.1 UCB Details
        2.11.2 UCB Major Business
        2.11.3 UCB Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.11.4 UCB Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 UCB Recent Developments and Future Plans
    2.12 Eli Lilly and Company
        2.12.1 Eli Lilly and Company Details
        2.12.2 Eli Lilly and Company Major Business
        2.12.3 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.12.4 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Eli Lilly and Company Recent Developments and Future Plans
    2.13 AstraZeneca
        2.13.1 AstraZeneca Details
        2.13.2 AstraZeneca Major Business
        2.13.3 AstraZeneca Immunoglobulin G Antibody Therapeutics Product and Solutions
        2.13.4 AstraZeneca Immunoglobulin G Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 AstraZeneca Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Immunoglobulin G Antibody Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Immunoglobulin G Antibody Therapeutics Players Market Share in 2021
        3.2.2 Top 10 Immunoglobulin G Antibody Therapeutics Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Immunoglobulin G Antibody Therapeutics Players Head Office, Products and Services Provided
    3.4 Immunoglobulin G Antibody Therapeutics Mergers & Acquisitions
    3.5 Immunoglobulin G Antibody Therapeutics New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Immunoglobulin G Antibody Therapeutics Revenue and Market Share by Type (2017-2022)
    4.2 Global Immunoglobulin G Antibody Therapeutics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2017-2022)
    5.2 Global Immunoglobulin G Antibody Therapeutics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Immunoglobulin G Antibody Therapeutics Revenue by Type (2017-2028)
    6.2 North America Immunoglobulin G Antibody Therapeutics Revenue by Application (2017-2028)
    6.3 North America Immunoglobulin G Antibody Therapeutics Market Size by Country
        6.3.1 North America Immunoglobulin G Antibody Therapeutics Revenue by Country (2017-2028)
        6.3.2 United States Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        6.3.3 Canada Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        6.3.4 Mexico Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Immunoglobulin G Antibody Therapeutics Revenue by Type (2017-2028)
    7.2 Europe Immunoglobulin G Antibody Therapeutics Revenue by Application (2017-2028)
    7.3 Europe Immunoglobulin G Antibody Therapeutics Market Size by Country
        7.3.1 Europe Immunoglobulin G Antibody Therapeutics Revenue by Country (2017-2028)
        7.3.2 Germany Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        7.3.3 France Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        7.3.5 Russia Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        7.3.6 Italy Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue by Type (2017-2028)
    8.2 Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue by Application (2017-2028)
    8.3 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region
        8.3.1 Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue by Region (2017-2028)
        8.3.2 China Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        8.3.3 Japan Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        8.3.4 South Korea Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        8.3.5 India Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        8.3.7 Australia Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Immunoglobulin G Antibody Therapeutics Revenue by Type (2017-2028)
    9.2 South America Immunoglobulin G Antibody Therapeutics Revenue by Application (2017-2028)
    9.3 South America Immunoglobulin G Antibody Therapeutics Market Size by Country
        9.3.1 South America Immunoglobulin G Antibody Therapeutics Revenue by Country (2017-2028)
        9.3.2 Brazil Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        9.3.3 Argentina Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Immunoglobulin G Antibody Therapeutics Revenue by Type (2017-2028)
    10.2 Middle East & Africa Immunoglobulin G Antibody Therapeutics Revenue by Application (2017-2028)
    10.3 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country
        10.3.1 Middle East & Africa Immunoglobulin G Antibody Therapeutics Revenue by Country (2017-2028)
        10.3.2 Turkey Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
        10.3.4 UAE Immunoglobulin G Antibody Therapeutics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Immunoglobulin G Antibody Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?